Keywords: gsk, hycamtin, gets, positive, chmp, feedback, uk

GSK's Hycamtin gets positive CHMP feedback

Article | 05 December 2005

Print This

UK drug major GlaxoSmithKline says that Hycamtin (topotecan powder), the firm's treatment for relapsed small-cell lung cancer, has received a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in